initial public offerings (IPOs) trading on American exchanges
Showing posts with label AMTB. Show all posts
Showing posts with label AMTB. Show all posts

Monday, December 16, 2019

IPOs this week : Dec 16 - 20, 19 (wk 51)

No new U.S. pricings are expected in the week ahead.

IPO lockup expirations
  • Stoke Therapeutics (NASDAQ:STOK) on December 16; 
  • Grocery Outlet (NASDAQ:GO), Personalis (NASDAQ:PSNL), Prevail Therapeutics (NASDAQ:PRVL), Atreca (NASDAQ:BCEL) and Akero Therapeutics (NASDAQ:AKRO) on December 17; 
  • Artelo Biosciences (NASDAQ:ARTL) on December 18 and 
  • Amerant (NASDAQ:AMTB) on December 19. 
Of the bunch, Grocery Outlet might be the one to watch with shares up over 30% since the IPO.

IPO quiet period expirations
There is also an analyst quiet period expiration for SiTime (NASDAQ:SITM) on December 16 to keep tabs on.

Sunday, June 16, 2019

IPOs this week : June 17 - 21, 19

IPOs expected to price
  • Stoke Therapeutics (STOK) is expected to price its IPO on June 18, 
  • Akero Therapeutics (AKRO), Atreca (BCEL), Dermavant Sciences (DRMT), Grocery Outlet Holdings (GO), Personalis (PSNL) and Prevail Therapeutics (PRVL) are all slated to price on June 20.


IPO quiet period/lockup expirations 
Quiet periods end on
  • Rattler Midstream (NASDAQ:RTLR), Ideaya Biosciences (NASDAQ:IDYA) and Bicycle Therapeutics (NASDAQ:BCYC) on June 17. 
  • Meanwhile, share lockups expire on Amarant (NASDAQ:AMTB), LiveXLive Media (NASDAQ:LIVX) and Datasea (NASDAQ:DTSS) on June 17 - as well as Cardiol Therapeutics (OTCPK:CRTPF) on June 18. 
  • Over in Tokyo, some shares of SoftBank Corp. (OTCPK:SOBKY) are also due to be freed up on June 17.
Spotlight on Slack:
Slack Technologies (WORK) expects to be valued by investors at $16B to $17B when the workspace chat/collaboration software company lists shares on June 20 in a direct listing. For the fiscal year ending in January, Slack expects to churn up revenue of $590M (+50% Y/Y) but estimates for the bottom line vary widely. Per public filings, Slack's shares have traded at prices ranging from $8.37 to $31.50 per share in the private market.